Intervista a Intervista a Leilani C. Latimer, VP Global Marketing, Partnerships & Commercial Operations, Zephyr Health
It’s been an exciting year at Zephyr Health, not just for the amazing new capabilities delivered in our unique, Insights-as-a-Service solution for Life Sciences companies, but also with numerous, prestigious recognition from the industry and beyond.
In May, our founder and Executive Chairman William King was recognized by PM360, a leading life sciences trade magazine, as one of their Elite 100 within the Entrepreneur category. Out of more than 500 submissions, 100 winners were selected across 18 categories.
Now in its third year, the PM360 Elite – Exceptional, Leaders, Innovators Transformers and Entrepreneurs – represent the most influential people in the healthcare industry, and King was recognized for helping life sciences companies engage the right physicians and institutions better to connect their treatments, diagnostics, or medical devices to patients through efficient use of global health data and predictive insights.
Zephyr Health was then recognized as one of the Top 48 companies bringing Artificial Intelligence to healthcare by Redox, an applications and engineering group service the healthcare industry.
And, just last week, Zephyr Health was selected as a winner of Red Herring’s Top 100 North America award, for its innovative services and solutions. Zephyr Health’s patented machine learning automates the arduous process of linking the vast amount of disparate data available in healthcare today with internal customer data and purchased data to provide robust insights on physicians, accounts, and institutions for commercial transformation.
Winners of the Red Herring award, one of the technology industry’s most prestigious prizes, are among the continent’s brightest and most innovative private ventures. Their place among North America’s tech elite has been chosen by Red Herring’s editorial team, during a months-long process that takes into account criteria including disruptive impact, proof of concept, financial performance, market footprint, and quality of management.
“This is an exceptional time in Zephyr Health’s growth and we are excited to be recognized by such a prestigious and influential group” said Lance Scott, chief executive officer of Zephyr Health. “We see the Red Herring’s North America Top 100 award as additional recognition of the unique approach Zephyr is taking to provide actionable insights for our life science clients, based on big data analytics powered by machine learning. We are proud to be included among this year’s winners.”
About Zephyr Health: Zephyr Health helps Life Sciences companies – pharmaceutical, biotech, medical device and diagnostics – engage the right physicians, accounts and institutions using insights from global health data. Zephyr Illuminate™ is a leading Insights-as-a-Service solution that integrates thousands of data sources to create precise and predictive insights. From pre-launch to product maturity, Life Sciences companies can make confident decisions faster with data-driven targeting and deep customer profiles. Zephyr Health’s customers include several of the Top 10 Pharmaceutical, Biotech and Medical Device companies.
Zephyr Health is a privately held company headquartered in San Francisco with offices in London, UK, and Pune, India. Zephyr Health is venture backed by Google Ventures, Kleiner Perkins Caufield & Byers, and Icon Ventures. Digital Health. For more information, please visit: www.zephyrhealth.com.
Contact info: Leilani Latimer